|
US4404207A
(en)
|
1981-11-06 |
1983-09-13 |
Riker Laboratories, Inc. |
Antimicrobial 8-substituted benzo [IJ]quinolizines
|
|
US5138089A
(en)
*
|
1986-06-27 |
1992-08-11 |
The Procter & Gamble Company |
Chromophores, sunscreen compositions and methods for preventing sunburn
|
|
AU1868195A
(en)
|
1994-01-28 |
1995-08-15 |
Cell Therapeutics, Inc. |
Cell signaling inhibitors
|
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
US6455564B1
(en)
|
1999-01-06 |
2002-09-24 |
Pharmacia & Upjohn Company |
Method of treating sexual disturbances
|
|
US7101869B2
(en)
|
1999-11-30 |
2006-09-05 |
Pfizer Inc. |
2,4-diaminopyrimidine compounds useful as immunosuppressants
|
|
US7345051B2
(en)
|
2000-01-31 |
2008-03-18 |
Genaera Corporation |
Mucin synthesis inhibitors
|
|
KR100865775B1
(ko)
|
2000-11-20 |
2008-10-29 |
메르크 파텐트 게엠베하 |
키랄 광이성질성 화합물
|
|
WO2003033517A1
(en)
|
2001-10-17 |
2003-04-24 |
The University Of British Columbia |
Ship 1 modulators
|
|
EP1460067A4
(en)
|
2001-11-26 |
2005-12-07 |
Takeda Pharmaceutical |
BICYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE
|
|
HUP0203976A3
(en)
|
2002-11-15 |
2004-08-30 |
Sanofi Aventis |
Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
|
|
TWI322012B
(en)
|
2002-12-20 |
2010-03-21 |
Organon Nv |
Tetrahydroquinoline derivatives
|
|
IN2003CH00929A
(cg-RX-API-DMAC7.html)
|
2003-11-13 |
2008-10-06 |
|
|
|
WO2005066162A1
(en)
|
2003-12-23 |
2005-07-21 |
Human Biomolecular Research Institute |
Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
|
|
EP1732541A4
(en)
|
2004-04-07 |
2008-03-05 |
Takeda Pharmaceutical |
CYCLIC COMPOUNDS
|
|
US20060106020A1
(en)
|
2004-04-28 |
2006-05-18 |
Rodgers James D |
Tetracyclic inhibitors of Janus kinases
|
|
US20080318989A1
(en)
|
2005-12-19 |
2008-12-25 |
Burdick Daniel J |
Pyrimidine Kinase Inhibitors
|
|
US20070203236A1
(en)
|
2006-01-11 |
2007-08-30 |
Smith Jeffrey W |
Novel antagonists of the human fatty acid synthase thioesterase
|
|
US20080075692A1
(en)
|
2006-05-09 |
2008-03-27 |
Perrine Susan P |
Methods for treating blood disorders
|
|
EP1878724A1
(en)
|
2006-07-15 |
2008-01-16 |
sanofi-aventis |
A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
CA2574531C
(en)
|
2007-01-19 |
2016-10-25 |
The University Of British Columbia |
Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
|
|
US8476458B2
(en)
|
2007-06-21 |
2013-07-02 |
The Wistar Institute |
Methods and compositions for modulating P300/CBP activity
|
|
WO2009000413A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi-Aventis |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
US8222417B2
(en)
|
2007-06-27 |
2012-07-17 |
Taisho Pharmaceutical Co., Ltd |
Compound having 11β-HSD1 inhibitory activity
|
|
TW200930369A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
|
AR072008A1
(es)
|
2008-06-13 |
2010-07-28 |
Merck & Co Inc |
Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38
|
|
MX2010014066A
(es)
|
2008-06-16 |
2011-06-01 |
Univ Tennessee Res Foundation |
Compuestos para el tratamiento del cancer.
|
|
WO2010110380A1
(ja)
*
|
2009-03-27 |
2010-09-30 |
興和株式会社 |
縮合ピペリジン化合物及びこれを含有する医薬
|
|
WO2010118208A1
(en)
|
2009-04-09 |
2010-10-14 |
Exelixis, Inc. |
Benzoxazepin-4- (5h) -yl derivatives and their use to treat cancer
|
|
CA2758904C
(en)
|
2009-04-15 |
2017-04-04 |
Jw Pharmaceutical Corporation |
Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
|
|
WO2010138490A1
(en)
|
2009-05-26 |
2010-12-02 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
|
|
CN102459248A
(zh)
|
2009-05-26 |
2012-05-16 |
埃克塞里艾克西斯公司 |
作为PI3K/mTOR抑制剂的苯并氧杂环庚三烯以及它们使用与制造方法
|
|
US9005670B2
(en)
|
2010-01-05 |
2015-04-14 |
The Johns Hopkins University |
Use of histone acetyltransferase inhibitors as novel anti-cancer therapies
|
|
JP5879273B2
(ja)
|
2010-03-01 |
2016-03-08 |
ジーティーエックス・インコーポレイテッド |
癌を処置するための化合物
|
|
US8969349B2
(en)
*
|
2010-05-26 |
2015-03-03 |
Sunovion Pharmaceuticals Inc. |
Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
|
|
US8906943B2
(en)
|
2010-08-05 |
2014-12-09 |
John R. Cashman |
Synthetic compounds and methods to decrease nicotine self-administration
|
|
WO2012080729A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
CASEIN KINASE 1δ (CK1δ) INHIBITORS
|
|
US8765978B2
(en)
|
2010-12-16 |
2014-07-01 |
Transitions Optical, Inc. |
Method of making indeno-fused naphthol materials
|
|
EP2678050B1
(en)
|
2011-02-24 |
2020-10-14 |
Emory University |
Noggin blocking compositions for ossification and methods related thereto
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
|
WO2013148114A1
(en)
|
2012-03-30 |
2013-10-03 |
University Of Florida Research Foundation, Inc. |
P300/cbp inhibitors and methods of use
|
|
US9211333B2
(en)
|
2012-06-05 |
2015-12-15 |
Hong Kong Baptist University |
Anti-cancer agents synthesized based on miliusane compounds
|
|
US9593115B2
(en)
|
2012-09-21 |
2017-03-14 |
Advinus Therapeutics Ltd. |
Substituted fused tricyclic compounds, compositions, and medicinal applications thereof
|
|
RU2543485C2
(ru)
|
2013-02-26 |
2015-03-10 |
Андрей Александрович Иващенко |
Гетероциклические агонисты рецепторов желчных кислот tgr5, фармацевтическая композиция, способы их получения и применения
|
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
SI3010503T1
(sl)
|
2013-06-21 |
2020-07-31 |
Zenith Epigenetics Ltd. |
Novi biciklični inhibitorji bromodomene
|
|
JP6461118B2
(ja)
|
2013-06-21 |
2019-01-30 |
ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． |
ブロモドメイン阻害剤としての新規の置換された二環式化合物
|
|
US9975896B2
(en)
|
2013-07-25 |
2018-05-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
DE102013215912B3
(de)
|
2013-08-12 |
2015-02-26 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Farbneutral beschichteter kupferhaltiger Gegenstand, Verfahren zu dessen Herstellung sowie Verwendung einer entsprechenden farbneutralen Beschichtung
|
|
TW201605859A
(zh)
|
2013-11-14 |
2016-02-16 |
必治妥美雅史谷比公司 |
作為酪蛋白激酶１δ／ε抑制劑之新穎經取代之吡唑并－哌
|
|
RU2720237C2
(ru)
|
2013-11-18 |
2020-04-28 |
Форма Терапеутикс, Инк. |
Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
|
|
CN110627770A
(zh)
|
2013-11-18 |
2019-12-31 |
福马疗法公司 |
作为bet溴域抑制剂的四氢喹啉组成物
|
|
EP3193866A1
(en)
|
2014-09-19 |
2017-07-26 |
Genentech, Inc. |
Use of cbp/ep300 and bet inhibitors for treatment of cancer
|
|
EP3632915A1
(en)
*
|
2014-11-27 |
2020-04-08 |
Genentech, Inc. |
4,5,6,7-tetrahydro-1 h-pyrazolo[4,3-c]pyridin-3-amine compounds as cbp and/or ep300 inhibitors
|
|
WO2016110821A1
(en)
|
2015-01-08 |
2016-07-14 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
|
WO2016128908A1
(en)
|
2015-02-12 |
2016-08-18 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
WO2017197056A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Bromodomain targeting degronimers for target protein degradation
|
|
ES2910787T3
(es)
|
2016-05-12 |
2022-05-13 |
Univ Michigan Regents |
Inhibidores de ASH1L y métodos de tratamiento con los mismos
|
|
EP3464270B1
(en)
|
2016-05-24 |
2022-02-23 |
Genentech, Inc. |
Heterocyclic inhibitors of cbp/ep300 and their use in the treatment of cancer
|
|
GB201617630D0
(en)
|
2016-10-18 |
2016-11-30 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201617627D0
(en)
|
2016-10-18 |
2016-11-30 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
WO2018195155A1
(en)
*
|
2017-04-18 |
2018-10-25 |
Celgene Quanticel Research, Inc. |
Therapeutic compounds
|
|
TWI795440B
(zh)
*
|
2017-09-15 |
2023-03-11 |
美商佛瑪治療公司 |
作為ＣＢＰ／ｐ３００抑制劑之四氫─咪唑並喹啉化合物
|
|
US10870648B2
(en)
*
|
2018-06-29 |
2020-12-22 |
Forma Therapeutics, Inc. |
Inhibiting CREB binding protein (CBP)
|